HCA Healthcare, Inc. $HCA Shares Sold by Strs Ohio

Key Points

• Strs Ohio trimmed its stake in HCA by 3.9%, selling 3,553 shares to hold 86,727 shares worth $40.49M, while company insiders sold 15,214 shares (~$7.8M) over the last quarter, leaving insiders with 1.50% ownership.
• Several institutional investors boosted positions—Viking Global raised holdings by 58.5% to 1,872,133 shares and others (Danske, Zurich, Mondrian, Public Sector Pension) added large stakes—leaving institutions owning 62.73% of the stock.
• HCA slightly missed quarterly EPS ($7.15 vs. $7.19) with revenue up 4.3%, set FY2026 guidance of 29.10–31.50 EPS, and declared a quarterly dividend of $0.78 ($3.12 annualized, ~0.7% yield).

Strs Ohio decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 86,727 shares of the company's stock after selling 3,553 shares during the period. Strs Ohio's holdings in HCA Healthcare were worth $40,489,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Viking Global Investors LP increased its holdings in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after acquiring an additional 690,773 shares during the last quarter. Danske Bank A S acquired a new stake in shares of HCA Healthcare during the third quarter worth $115,530,000. Zurich Insurance Group Ltd FI boosted its holdings in shares of HCA Healthcare by 3,755.9% in the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company's stock valued at $115,036,000 after buying an additional 262,912 shares during the period. Mondrian Investment Partners LTD acquired a new stake in HCA Healthcare during the third quarter worth about $106,605,000. Finally, Public Sector Pension Investment Board boosted its stake in HCA Healthcare by 127.3% in the third quarter. Public Sector Pension Investment Board now owns 369,704 shares of the company's stock valued at $157,568,000 after acquiring an additional 207,070 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company's stock, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the company's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 15,214 shares of company stock valued at $7,797,595 over the last quarter. Company insiders own 1.50% of the company's stock.

HCA Healthcare Price Performance

NYSE HCA opened at $433.73 on Friday. The firm has a market capitalization of $96.50 billion, a PE ratio of 14.92, a P/E/G ratio of 1.37 and a beta of 1.19. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company's 50 day simple moving average is $497.66 and its 200 day simple moving average is $485.93.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 10.73%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Truist Financial cut their price target on HCA Healthcare from $546.00 to $535.00 and set a "buy" rating on the stock in a report on Monday, April 27th. Leerink Partners reduced their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating for the company in a report on Monday, April 27th. Barclays dropped their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an "overweight" rating on the stock in a report on Monday, April 27th. Jefferies Financial Group restated a "buy" rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Weiss Ratings reaffirmed a "buy (b)" rating on shares of HCA Healthcare in a report on Friday, March 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $520.55.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.